| Autor: |
Sivaprasad, Sobha, Prevost, A Toby, Vasconcelos, Joana C, Riddell, Amy, Murphy, Caroline, Kelly, Joanna, Bainbridge, James, Tudor-Edwards, Rhiannon, Hopkins, David, Hykin, Philip, Bhatnagar, A, Burton, B, Chakravarthy, U, Eleftheriadis, H, Empeslidis, T, Gale, R, George, S, Habib, M, Kelly, S, Lotery, A, McKibbin, M, Membrey, L, Menon, G, Mushtaq, B, Nicholson, L, Ramu, J, Osoba, O, Patel, J, Prakash, P, Purbrick, R, Ross, A, Stylianides, A, Talks, J, Chakravarthy, U, Harding, S, Peto, T, Yeo, S T, Laidlaw, Alistair, Amoaku, Winfried, Hood, Gillian, Hitman, Graham A, Preece, Daniel, Burns, Paul, Walker, Sarah, Mensah, Evelyn, Karia, Niral |
| Zdroj: |
The Lancet; June 2017, Vol. 389 Issue: 10085 p2193-2203, 11p |
| Abstrakt: |
Proliferative diabetic retinopathy is the most common cause of severe sight impairment in people with diabetes. Proliferative diabetic retinopathy has been managed by panretinal laser photocoagulation (PRP) for the past 40 years. We report the 1 year safety and efficacy of intravitreal aflibercept. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
